Další formáty:
BibTeX
LaTeX
RIS
@proceedings{2220969,
author = {Straka, Matej and Rohan, Tomáš and Matkulčík, Peter and Hustý, Jakub and Andrašina, Tomáš},
booktitle = {CIRSE 2022},
doi = {http://dx.doi.org/10.1007/s00270-022-03246-4},
keywords = {hepatocellular carcinoma; HCC; transarterial chemoembolisation; TACE; complications; degradable particles; DSM TACE},
language = {eng},
title = {Assessment of rate of major complications in transarterial chemoembolization using degradable starch microspheres versus permanent embolization particles in patients with hepatocellular carcinoma},
url = {https://programme.cirse2022.cirse.org/cirse2022/crs/assessment-of-rate-of-major-complications-in-transarterial-chemoembolization-using-degradable-starch-microspheres-versus-permanent-embolization-particles-in-patients-with-hepatocellular-carcinoma},
year = {2022}
}
TY - CONF
ID - 2220969
AU - Straka, Matej - Rohan, Tomáš - Matkulčík, Peter - Hustý, Jakub - Andrašina, Tomáš
PY - 2022
TI - Assessment of rate of major complications in transarterial chemoembolization using degradable starch microspheres versus permanent embolization particles in patients with hepatocellular carcinoma
KW - hepatocellular carcinoma
KW - HCC
KW - transarterial chemoembolisation
KW - TACE
KW - complications
KW - degradable particles
KW - DSM TACE
UR - https://programme.cirse2022.cirse.org/cirse2022/crs/assessment-of-rate-of-major-complications-in-transarterial-chemoembolization-using-degradable-starch-microspheres-versus-permanent-embolization-particles-in-patients-with-hepatocellular-carcinoma
N2 - Purpose: To analyze whether transarterial chemoembolization (TACE) using degradable starch microspheres (DSM-TACE) or permanent embolizing particles (DEB-TACE) cause significant difference in rate of major periprocedural complications in patients with hepatocellular carcinoma (HCC). Materials and methods: Prospective assessment of major periprocedural complications in 226 TACE procedures between 2018-2021 in 57 consecutive patients with HCC was performed. Study group consists of 110 DSM-TACE procedures, the control group consists of 116 procedures using permanent embolizing particles. Major complications were followed up to 30 days after each TACE (contrast-enhanced CT, laboratory parameters, clinical status). Our data underwent statical analyses (chi-squared test). Results: There was significant difference in complication per procedure in the study and the control group (3% vs 14% p=0,006). Complications after TACE included severe postembolization syndrome (n=11), liver ischemia caused by reflux of permanent particles (n=4), liver abscess (n=2), cholangitis (n=2), allergic reaction (n=1). Conclusion: Patients with HCC treated with TACE using permanent embolization particles have significantly higher frequency of major postprocedural complication compared to patients with HCC treated with TACE using degradable particles.
ER -
STRAKA, Matej, Tomáš ROHAN, Peter MATKULČÍK, Jakub HUSTÝ a Tomáš ANDRAŠINA. Assessment of rate of major complications in transarterial chemoembolization using degradable starch microspheres versus permanent embolization particles in patients with hepatocellular carcinoma. In \textit{CIRSE 2022}. 2022. Dostupné z: https://dx.doi.org/10.1007/s00270-022-03246-4.
|
